1809336-39-7 (Valemetostat,Valemetostat)

Valemetostat;60RD0234VE;Valemetostat [INN];Ezharmia;Valemetostat?;(2R)-7-chloro-2-[4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide;AC-36896;(R)-7-chloro-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-((1r,4R)-4-(dimethylamino)cyclohexyl)-2,4-dimethylbenzo[d][1,3]dioxole-5-carboxamide;NSC-813381;NSC813381;GTPL12282;Valemetostat (INN);VALEMETOSTAT [WHO-DD];(R)-OR-S2;DS-3201;G16372;EZH1/2 inhibitor DS-3201;DS-3201b;Valemetostat 2HCl;EX-A3423;MS-29068;DS3201;CHEMBL4597193;CS-0039740;UNII-60RD0234VE;DA-58943;SCHEMBL18639210;D11551;AKOS040740515;SCHEMBL18393626;1809336-39-7;SCHEMBL18393627;HY-109108;

MFCD31692361

SSDRNUPMYCFXGM-ZZHSESOFSA-N

1S/C26H34ClN3O4/c1-14-11-15(2)29-25(32)20(14)13-28-24(31)19-12-21(27)23-22(16(19)3)33-26(4,34-23)17-7-9-18(10-8-17)30(5)6/h11-12,17-18H,7-10,13H2,1-6H3,(H,28,31)(H,29,32)/t17?,18?,26-/m1/s1

ClC1C=C(C(NCC2C(NC(C)=CC=2C)=O)=O)C(C)=C2C=1O[C@](C)(C1CCC(CC1)N(C)C)O2